We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+7.87%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$15.9B
AUM Growth
+$1.24B
(+8.5%)
Cap. Flow
+$523M
Cap. Flow
% of AUM
3.3%
Top 10 Holdings %
Top 10 Hldgs %
35.05%
Holding
1,298
New
139
Increased
794
Reduced
319
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$228M |
| 2 |
KraneShares CSI China Internet ETF
KWEB
|
+$41.5M |
| 3 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$35.7M |
| 4 |
Intel
INTC
|
+$34.7M |
| 5 |
Blackstone
BX
|
+$34.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
A10 Networks
ATEN
|
+$258M |
| 2 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$255M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$197M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$83.7M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.02% |
| 2 | Financials | 19.16% |
| 3 | Energy | 5.34% |
| 4 | Healthcare | 4.01% |
| 5 | Industrials | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Karyopharm Therapeutics
KPTI
$159M
| $2.61M | 0.02% |
16,851
-1,193
| -7% | -$173K |
|
577
Allogene Therapeutics
ALLO
$680M
| $2.61M | 0.02% |
99,943
+13,360
| +15% | +$381K |
|
|
DRNA
578
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.61M | 0.02% |
69,820
-50,037
| -42% | -$1.53M |
|
579
MGIC Investment
MTG
$6.25B
| $2.6M | 0.02% |
191,344
+21,167
| +12% | +$304K |
|
|
PING
580
DELISTED
Ping Identity Holding Corp.
PING
| $2.6M | 0.02% |
113,444
-21,449
| -16% | -$505K |
|
581
Rithm Capital
RITM
$5.51B
| $2.6M | 0.02% |
245,040
+36,254
| +17% | +$385K |
|
582
Emergent Biosolutions
EBS
$375M
| $2.59M | 0.02% |
41,070
+4,124
| +11% | +$265K |
|
583
Kratos Defense & Security Solutions
KTOS
$8.66B
| $2.59M | 0.02% |
90,817
+12,778
| +16% | +$338K |
|
|
BLUE
584
DELISTED
bluebird bio
BLUE
| $2.58M | 0.02% |
6,217
-9,780
| -61% | -$3.87M |
|
585
Neurocrine Biosciences
NBIX
$18.7B
| $2.57M | 0.02% |
26,450
-7,886
| -23% | -$756K |
|
586
Zoetis
ZTS
$31.9B
| $2.57M | 0.02% |
13,810
+1,857
| +16% | +$323K |
|
587
8x8 Inc
EGHT
$262M
| $2.57M | 0.02% |
92,578
-18,074
| -16% | -$513K |
|
588
Linde
LIN
$235B
| $2.57M | 0.02% |
8,890
+4,407
| +98% | +$1.28M |
|
589
PTC Therapeutics
PTCT
$6.26B
| $2.57M | 0.02% |
60,737
+3,733
| +7% | +$160K |
|
590
Alkermes
ALKS
$8.39B
| $2.56M | 0.02% |
104,215
-67,349
| -39% | -$1.5M |
|
591
Kemper
KMPR
$1.71B
| $2.55M | 0.02% |
34,520
+3,409
| +11% | +$263K |
|
|
PPBI
592
DELISTED
Pacific Premier Bancorp
PPBI
| $2.54M | 0.02% |
60,172
+632
| +1% | +$28.1K |
|
593
GE Aerospace
GE
$368B
| $2.54M | 0.02% |
37,844
+5,859
| +18% | +$391K |
|
594
Delek US
DK
$4.15B
| $2.53M | 0.02% |
+117,149
| New | +$2.64M |
|
595
Fate Therapeutics
FATE
$293M
| $2.52M | 0.02% |
29,067
-55,708
| -66% | -$4.49M |
|
596
Home BancShares
HOMB
$6.25B
| $2.52M | 0.02% |
102,040
+25,806
| +34% | +$697K |
|
597
Kymera Therapeutics
KYMR
$8.8B
| $2.5M | 0.02% |
51,601
-209
| -0.4% | -$9.07K |
|
598
Rocket Pharmaceuticals
RCKT
$351M
| $2.5M | 0.02% |
56,487
-5,646
| -9% | -$245K |
|
|
SGMO
599
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.5M | 0.02% |
209,063
-79,667
| -28% | -$902K |
|
600
Xerox
XRX
$456M
| $2.49M | 0.02% |
106,133
-20,071
| -16% | -$485K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Rafferty Asset Management held 1,298 positions worth $15.9B, up 8.5% from $14.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $523M of net new capital in Q2 2021, opening 139 new positions and adding to 794 existing holdings. Its largest new stake was Blackstone: 386,473 shares worth $37.5M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $197M trimmed.
- Rafferty Asset Management's largest Q2 2021 buy was Blackstone: 386,473 shares worth $37.5M.
- Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $228M increase.
- Rafferty Asset Management's biggest Q2 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $197M.
- Rafferty Asset Management fully exited A10 Networks in Q2 2021, selling an estimated $258M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $15.9B portfolio in Q2 2021.
- Rafferty Asset Management opened 139 new positions and closed 45 in Q2 2021.
- Rafferty Asset Management's portfolio value rose 8.5% quarter-over-quarter to $15.9B.
Based on Rafferty Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.